{"schema_version":"secwatch.filing_event.v1","accession":"0000805928-21-000130","form_type":"8-K","ticker":"AXGN","cik":"0000805928","company_name":"Axogen, Inc.","filed_at":"2021-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.804371+00:00","generated_at":"2026-06-30T04:39:54.794105+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Axogen appoints John H. Johnson to board, effective July 19, 2021","bullets":["Board increased from eight to nine members; Johnson appointed effective July 19, 2021.","Johnson is CEO of Strongbridge Biopharma with 30+ years of biopharma experience.","He will serve on the Governance, Nominating and Sustainability Committee and Science and Technology Committee.","Standard director compensation: quarterly cash retainers ($10K board, $1.25K per committee) and stock option grants.","Johnson previously held senior roles at Eli Lilly, J&J, ImClone, and Dendreon."],"urls":{"canonical":"https://secwatch.observer/filing/0000805928-21-000130","json":"https://secwatch.observer/filing/0000805928-21-000130.json","markdown":"https://secwatch.observer/filing/0000805928-21-000130.md","text":"https://secwatch.observer/filing/0000805928-21-000130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000130/0000805928-21-000130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000130/axgn-20210716.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:39:54.794105+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"df6c194f3a","claim":"John Johnson was appointed as Director at Axogen, Inc..","evidence_excerpt":"On July 16, 2021, the board of directors (the “Board”) of Axogen, Inc. (the “Company”) increased the size of the Board from eight to nine members, and appointed John Johnson as a new director, effective July 19, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000130/0000805928-21-000130-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}